Lockdown! Collins, a household name for producing the rival to the Oxford English Dictionary, has chosen ‘lockdown’ as its word of the year for 2020. In fact, our worlds have been impacted so greatly by the new Coronavirus that 6 out of the shortlisted 10 words included reference to the pandemic. Biting at the heels of 2016 winner ‘Brexit’, 2020’s Megxit failed to take the crown. Two social media phenomena alongside ‘BLM’ complete the list. With news yesterday of significant progress in the Pfizer-BioNTech vaccine trial, perhaps 2021 will contain no such vaccine related shortlisters. Just as Oxford’s word of the year in 2008 – Credit Crunch – faded into 2009’s ‘simples’ – a reference to comparison website slogan Compare the Meerkat, I wonder what next year and potential return to normality will bring!
Yesterday was a turbulent day for markets following the confirmation over the weekend that Democratic nominee Biden is now President-elect. News of 90% successful immune-response in trials of some 43,000 people led markets to rally with major US and European stock indices up 5% by lunchtime. Announcements in the UK by Chancellor Rishi Sunak and PM Johnson continued to stoke a volatile market. The ‘risk-on’ mood in markets prompted by the vaccine announcement encouraged emerging market and commodity currencies higher at the expense of safehavens such as the US Dollar and Japanese Yen. As the rally began to fade in the later afternoon, markets retraced slightly.
Health Secretary Matt Hancock has asked the NHS to prepare to roll out a vaccine as early as December this morning. The style of the Pfizer-BioNTech vaccine is more complex than many other vaccines. The data yesterday however has encouraged hope of successful projects relying on similar technology and fundamentals. Whilst a 90% success rate might sound good in many contexts a lot of the popular reaction was quite rightly: what about the other 10%? That will still leave 780m people vulnerable to the disease across the globe, significantly more than have died from the virus to date. However, the 90% success rate far surpasses regulators requirements for a vaccine and widespread immunisation, just as a herd immunity strategy, can stop transmission once critical mass is reached. Therefore yesterday’s rally was strong and, more importantly, deserved.
Reading yesterday’s data as the stimulus package that no central bank or treasury could deliver, interest rates spiked as prospects for a near-term economic recovery improved. Higher yields in the US-treasury market brought the 10-year note back in line with March’s high prompting some demand back into the US Dollar.
Discussion and Analysis by Charles Porter
Click Here to Subscribe to the SGM-FX Newsletter
Related Insights
Daily Brief – UK Economic Growth 2025
Humphrey Percy
Mon 28 Apr 2025
UK Economic Growth 2025 The range is from 0.5% to 1.6%. Funnily enough, and not sure what conclusions one can draw from this, the four most pessimistic forecasts are all banks – Nomura, UBS, NatWest and Barclays who lead the downbeat group at 0.5%. At the other end of the scale the acronym heavy ICAEW, […]
Daily Brief – UK Employment
Humphrey Percy
Wed 16 Apr 2025
UK Employment At 75.1%, employment for people aged 16-64 looks sort of OK depending on what that really means, but it does not alter the fact that there are currently 1.55 million people who are unemployed, or 4.4% of the potential workforce. Another much more significant number, is that there are currently 9.27 million people […]
Daily Brief – Eastern Europe and Central Asia
Humphrey Percy
Fri 25 Apr 2025
Eastern Europe and Central Asia Between 2010 and 2019 economic growth in this large geographic area averaged 4%. According to the World Bank, that growth will decelerate to 2.5% for the next 2 years and even stripping out Russia that will still be lower at 3.3%. Inflation, weak external demand from the EU, global uncertainty […]
